ArticleJournal of molecular histology2026
SIRT3-mediated DRP1 acetylation changes are associated with the restoration of mitochondrial function and alleviation of anterior cruciate ligament injury-induced osteoarthritis.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Mitochondrial dysfunction and endoplasmic reticulum stress (ERS) play critical roles in the development of osteoarthritis (OA). Sirtuin 3 (SIRT3), a mitochondrial deacetylase, has regulatory effects on OA, but whether it can influence OA progression by modulating the crosstalk between mitochondrial dysfunction and ERS remains unclear. Therefore, the aim of this study was to investigate the effects of SIRT3 on mitochondrial dysfunction and ERS in OA. Anterior cruciate ligament transection was performed to establish an OA rat model, and C28/I2 chondrocytes were treated with IL-1β to establish an in vitro OA cell model for experimental investigation. Hematoxylin and eosin (H&E) staining, Safranin O/Fast Green staining, MitoTracker Red staining, and JC-1 staining were used to assess OA progression in rats and C28/I2 cell damage. RT-qPCR and Western blotting were used to measure the expression levels of target genes and proteins. Coimmunoprecipitation was utilized to examine protein interactions and acetylation levels. The result shows that SIRT3 expression was downregulated in OA rats and IL-1β-induced C28/I2 cells. SIRT3 overexpression significantly alleviated pathological damage to rat articular cartilage tissues, reduced chondrocyte loss, improved matrix metabolism in articular cartilage tissues, and ultimately mitigated OA progression in rats. Moreover, SIRT3 overexpression inhibited IL-1β-induced ERS in C28/I2 cells, reduced the activation of the unfolded protein response, and improved mitochondrial function. Additionally, the mitochondrial Ca
Indexed as
Identifiers
42745069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.